Search

everythinglearnresearchcommunity

for

Search:↓

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.

New vitiligo treatments focus on controlling immune damage and restoring skin color.

Non-motor symptoms in myasthenia gravis are common and need early diagnosis for better management.

Kv1.3 blockers may help treat alopecia areata and promote hair regrowth.

Murine cytomegalovirus does not cause alopecia areata in these mice.

Targeting MIG and MCP-1 may help treat inflammation in alopecia areata.

Bexarotene gel shows promise as a new treatment for alopecia areata.

Haloperidol decanoate can cause alopecia areata.

Hair dye ingredient PPD can cause severe allergic reactions, including facial swelling.

Improving blood vessel health and controlling uric acid may help manage alopecia areata.

TEC kinases may help cause inflammation in vitiligo and could be targeted for treatment.

IL-13 protein is much higher in the skin of atopic dermatitis patients than in healthy skin.

Tofacitinib is an effective and safe treatment for alopecia areata.

The study identified key immune cell differences between mild and severe alopecia areata.

People with alopecia areata have fewer IL-10 producing immune cells, which might contribute to the condition.

The combined treatment improved scalp health in women with early-stage hair loss.

Nanocrystals improve alopecia areata treatment by better targeting hair follicles.

γδ T cells are crucial for early wound healing after a skin virus infection.

SOX10 in hair follicles is linked to inflammation in alopecia areata.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

AIRE deficiency causes hair loss similar to alopecia areata in mice.

Deleting the BRD4 protein in certain skin cells causes hair loss and skin inflammation.

ITK inhibitors may effectively treat alopecia areata.

Tofacitinib effectively reduces hair loss in children with alopecia areata but may cause mild side effects and relapses.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

The nail matrix has a reduced immune response, protecting it from autoimmunity.

Certain immune cells contribute to skin autoimmune diseases, and some treatments can reverse hair loss in these conditions.

Higher CD70 and CD27 gene expression in alopecia areata lesions predicts disease severity and activity.

γδT cells can protect hair follicles from alopecia areata and promote hair regrowth.

Tofacitinib helped a woman with total-body hair loss grow her hair back.